钆塞酸增强MRI门静脉期减影图像用于观察LI-RADS 2018版中的廓清与强化包膜特征
本研究纳入115例高危患者共120个经组织学证实的肝细胞癌,由两名独立观察者比较常规门静脉期图像与联合减影图像对廓清和强化包膜的检出。联合减影图像仅在T1加权等信号或高信号病灶中显著提高廓清检出(18个病灶中8个 vs 15个,p=0.0233),强化包膜检出在多数因素下显著提高(p<0.05),2个病灶的LI-RADS分类因此上调至5类。
要点
- 门静脉期减影图像可提高强化包膜检出,除病灶小于2cm外各因素下均显著(p<0.05)。
- 减影图像仅在T1加权等信号或高信号病灶中显著提高廓清检出(18个病灶中8个 vs 15个,p=0.0233)。
- 2个伴动脉期高强化病灶(1个LI-RADS 3类、1个4类)依据减影图像上调为5类。
核心结论
- 钆塞酸增强MRI门静脉期减影图像因能更好地显示强化包膜并提供显示廓清的额外获益,可上调肝细胞癌诊断的LI-RADS分类。
研究设计与样本
- 研究纳入115例高危患者共120个经组织学证实的肝细胞癌,由两名独立观察者判断常规门静脉期图像及联合相应减影图像上廓清和强化包膜的存在。
- 按病灶大小(<10mm、10-19mm、≥20mm)、平扫T1加权信号强度和病灶动脉期高强化进行亚组分析,评估减影成像上调LI-RADS 2018版分类对肝细胞癌诊断的增量价值。
关键影像表现/征象
- 常规门静脉期图像与联合减影图像比较,仅T1加权等信号或高信号病灶的廓清检出显著增加(18个病灶中8个 vs 15个,p=0.0233)。
- 强化包膜检出除病灶小于2cm外(36个病灶中5个 vs 9个,p=0.1336),其余各因素下均显著增加(p<0.05)。
诊断标准与关键数值
- 以组织学证实的肝细胞癌为参考,比较常规门静脉期图像与联合减影图像对廓清和强化包膜的检出,并据此评估LI-RADS 2018版分类上调情况。
- 2个伴动脉期高强化病灶(1个LI-RADS 3类、1个4类)依据门静脉期减影图像上调为5类。
临床应用与阅片要点
- 作者结论认为门静脉期减影成像可上调肝细胞癌诊断的LI-RADS分类,阅片时可结合减影图像观察强化包膜和廓清。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVE. The purpose of this study is to validate the use of subtraction images derived from gadoxetic acid-enhanced MRI for observation of washout and enhancing capsule in the diagnosis of hepatocellular carcinoma (HCC). MATERIALS AND METHODS. For 120 histologically verified HCCs in 115 high-risk patients, the presence of washout and enhancing capsule in the portal venous phase (PVP) on conventional MR images with and without corresponding subtraction images was determined by two independent observers. The incremental value of subtraction imaging in upgrading the categories outlined in the Liver Imaging Reporting and Data System (LI-RADS) version 2018 for the diagnosis of HCC was analyzed for different subgroups of patients classified on the basis of lesion size (< 10 mm, 10-19 mm, ≥ 20 mm), unenhanced T1-weighted signal intensity, and arterial phase hyperenhancement (APHE) of the lesions. RESULTS. When conventional PVP images were compared with the combination of conventional and subtraction PVP images, only T1-weighted isointensity or hyperintensity significantly increased the detection of washout (eight vs 15 of 18 lesions; p = 0.0233). Detection of enhancing capsule was significantly increased (p < 0.05) regardless of various factors, except for a lesion size of less than 2 cm (five vs nine of 36 lesions; p = 0.1336). Two lesions (one LI-RADS category 3 lesion and one LI-RADS category 4 lesion) with APHE were upgraded to category 5 on the basis of a review of PVP subtraction images. CONCLUSION. PVP subtraction imaging during gadoxetic acid-enhanced MRI can upgrade LI-RADS categories for the diagnosis of HCC because of its superior ability in depicting enhancing capsule and the incremental benefit of showing washout.
引用
- Chung JW, Yu JS, Choi JM, et al. Subtraction Images From Portal Venous Phase Gadoxetic Acid-Enhanced MRI for Observing Washout and Enhancing Capsule Features in LI-RADS Version 2018. AJR Am J Roentgenol. 2019. PMID: 31573851. doi:10.2214/AJR.18.20797
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。